Alyeska Investment Group, L.P. Veracyte, Inc. Transaction History

Alyeska Investment Group, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	BUY	$35.62 - $52.97 $91,151 - $135,550	2,559 Added 1.28%	203,129 $9.44 Million
Q2 2021 Aug 16, 2021	BUY	$32.94 - $56.62 $581,226 - $999,059	17,645 Added 9.65%	200,570 $8.02 Million
Q1 2021 May 17, 2021	SELL	$44.47 - $81.38 $976,294 - $1.79 Million	-21,954 Reduced 10.72%	182,925 $9.83 Million
Q3 2019 Nov 14, 2019	SELL	$23.87 - $30.93 $150,452 - $194,951	-6,303 Reduced 2.98%	204,879 $4.92 Million
Q2 2019 Aug 14, 2019	BUY	$22.1 - $28.56 $4.67 Million - $6.03 Million	211,182 New	211,182 $0

307

81.6M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.97B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.